FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 3052517 · Received April 11, 2013

Report

Report Number
2124215-2013-03914
Event Type
Injury
Date Received
April 11, 2013
Date of Event
January 10, 2013
Report Date
February 27, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
PMA / PMN Number
P910073
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT NOISE WAS OVERSENSED ON THE RIGHT VENTRICULAR (RV) LEAD RESULTING IN GREATER THAN TWO SECONDS OF PACING INHIBITION. THE PATIENT WAS NOT SYMPTOMATIC AT THE TIME OF PACING INHIBITION. THE NOISE WAS NOT ABLE TO BE REPRODUCED. THE SENSITIVITY WAS REPROGRAMMED TO RESOLVE THE ISSUE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
154924 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0128

Patients

Seq Age Sex Outcome Treatment
1 Life Threatening